Skip to main content

Viking Global Investors LP's Form 4 filing

Amylyx Pharmaceuticals, Inc. (AMLX) · filed Sep 9, 2022

Accession no.
0001140361-22-032970
Filed
Sep 9, 2022, 9:48 PM ET
Trade date
Sep 8-9, 2022
Filing delay
1 day
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 16 non-derivative transactions. Open-market sales total $41.7M. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Viking Global Investors LPCIK 000110380410% Owner
Halvorsen Ole AndreasCIK 000113300610% Owner
Ott David C.CIK 000162184210% Owner
Viking Global Opportunities Portfolio GP LLCCIK 000162947210% Owner
Viking Global Opportunities GP LLCCIK 000162947610% Owner
Viking Global Opportunities Illiquid Investments Sub-Master LPCIK 000162948210% Owner
Shabet Rose SharonCIK 000171139310% Owner
Viking Global Opportunities Parent GP LLCCIK 000188673810% Owner
Dragsa 96 LLCCIK 000190485410% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 8, 2022Common StockSSaleDisposed−80,715$27.28F7−$2,202,090.844,789,821Indirect
Sep 8, 2022Common StockSSaleDisposed−108,631$28.16F8−$3,058,581.854,681,190Indirect
Sep 8, 2022Common StockSSaleDisposed−159,026$29.14F9−$4,634,431.114,522,164Indirect
Sep 8, 2022Common StockSSaleDisposed−15,996$30.59F10−$489,277.654,506,168Indirect
Sep 8, 2022Common StockSSaleDisposed−111,102$32.23F11−$3,580,773.024,395,066Indirect
Sep 8, 2022Common StockSSaleDisposed−38,116$27.28F7−$1,039,892.152,261,884Indirect
Sep 8, 2022Common StockSSaleDisposed−51,298$28.16F8−$1,444,331.12,210,586Indirect
Sep 8, 2022Common StockSSaleDisposed−75,096$29.14F9−$2,188,492.692,135,490Indirect
Sep 8, 2022Common StockSSaleDisposed−7,554$30.59F10−$231,057.982,127,936Indirect
Sep 8, 2022Common StockSSaleDisposed−52,466$32.23F11−$1,690,958.192,075,470Indirect
Sep 9, 2022Common StockSSaleDisposed−312,353$29.87F12−$9,329,265.74,082,713Indirect
Sep 9, 2022Common StockSSaleDisposed−156,463$30.90F13−$4,834,127.793,926,250Indirect
Sep 9, 2022Common StockSSaleDisposed−6,654$31.44F14−$209,217.733,919,596Indirect
Sep 9, 2022Common StockSSaleDisposed−147,502$29.87F12−$4,405,545.491,927,968Indirect
Sep 9, 2022Common StockSSaleDisposed−73,886$30.90F13−$2,282,804.021,854,082Indirect
Sep 9, 2022Common StockSSaleDisposed−3,142$31.44F14−$98,792.021,850,940Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F7

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.00 to $27.85. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (7) through (14) of this Form 4.

Referenced by the price of 2 transactions in Table I.

F8

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.00 to $28.465.

Referenced by the price of 2 transactions in Table I.

F9

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $29.00 to $29.52.

Referenced by the price of 2 transactions in Table I.

F10

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.00 to $30.785.

Referenced by the price of 2 transactions in Table I.

F11

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $32.00 to $32.71.

Referenced by the price of 2 transactions in Table I.

F12

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $29.25 to $30.245.

Referenced by the price of 2 transactions in Table I.

F13

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.25 to $31.2475.

Referenced by the price of 2 transactions in Table I.

F14

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $31.25 to $31.61.

Referenced by the price of 2 transactions in Table I.

Remarks

(15) The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16a-3(j) under the Exchange Act. (16) Scott M. Hendler is signing on behalf of Mr. Halvorsen, Mr. Ott and Ms. Shabet, each individually and as an Executive Committee Member of VIKING GLOBAL PARTNERS LLC, on behalf of VIKING GLOBAL INVESTORS LP, as manager of DRAGSA 96 LLC and as an Executive Committee Member of VIKING GLOBAL OPPORTUNITIES PARENT GP LLC, on behalf of itself and VIKING GLOBAL OPPORTUNITIES GP LLC, VIKING GLOBAL OPPORTUNITIES PORTFOLIO GP LLC, and VIKING GLOBAL OPPORTUNITIES ILLIQUID INVESTMENTS SUB-MASTER LP, pursuant to authorization and designation letters dated February 9, 2021, which were filed with the Securities and Exchange Commission on June 7, 2021.

Read the full filing on SEC EDGAR (opens in a new tab)